Gyre Therapeutics Inc (GYRE) Price Prediction & ForecastGYREGyre Therapeutics Inc

Alphio's GYRE stock price prediction model matches the current Gyre Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $6.23 (+1.05%). The 1-week path is $6.53 (+5.84%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Gyre Therapeutics is not a good buy right now due to significant financial challenges and poor technical indicators. The current price is $6.08, and the RSI is at a very low 18.42, indicating oversold conditions. Additionally, the stock has seen a 13.64% decline over the last five days and a staggering 27.10% drop over the past year, reflecting ongoing struggles. The main risk is the company's widening net loss, which reached $11.66 million in Q2 2026, a 472% increase from the previous year, raising concerns about its profitability and sustainability.

Gyre Therapeutics Inc (GYRE) last closed at $6.17, gaining +1.31%. These facts feed the 1-day and 1-week GYRE price prediction above.